Skyepharma Competitors and Similar CompaniesClear all
Societal CDMO's competitors and similar companies include Array BioPharma and Amicus Therapeutics.
 Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 2006 | Founding Date 1998 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 21316% decrease | Employees 1101% increase | Employees 58415% increase |
Valuation ($) | Valuation ($) 116.1 m | Valuation ($) N/A | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $94.6m (FY, 2023) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $528.3m (FY, 2024) |
Cost of goods | Cost of goods $76.5m (FY, 2023) | Cost of goods $59.4m (FY, 2018) | Cost of goods $52.9m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $114.4m (FY, 2018) | Gross profit $475.4m (FY, 2024) |
Net income | Net income ($13.3m) (FY, 2023) | Net income ($147.7m) (FY, 2018) | Net income ($56.1m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Array BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company